{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acquired-purpura-fulminans","columns":[{"gene":"","key":"population-d142fa7fc96eaa58649c","label":"Acquired purpura fulminans","mondoId":"MONDO:0018854","onsetQualifier":null,"originColumnKey":"MONDO:0018854/ORPHA:49566","originalViews":[{"key":"MONDO:0018854/ORPHA:49566","label":"Acquired purpura fulminans","scopeLabel":"ORPHA:49566","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["044178408e27cdb8838e3e7beaf97494376775c49f2d0bf770737ff4c1938d62","2662fc3643bca780eb325211df2c9a2bdf56141e3aabdd98ef0b2618ac181963","39310c9bfc957fc8973a8d1fa401fde3067a16a09d69bdec9c81071f96b60d27","3fa84b50e11babb5cc5797ddc64e19e3fc99703c0bc6a5144cde0862bd618212","430984b3788bf292257e1f452af5a316862f348073b78810ea8d1f7d2e18c471","4ace8e7ed5e01dd1ad04ff79cc40446c1738d0337573693ed1464aedc3b0bea1","4b9a772f5085301d10831edc97003a3749313fa02d8e4a195be432a4111a7377","4dace2f4c746469366a9634a2c9169b3a2074a0088737ca5a4a22e4d5748d725","56a00600c8b3141cd9a7465479362c239601f1352a75fcb1ee7fb389bf4b7b12","668e4a5ce6605fe5e7dbae54d8cf0b0de83c0ad2c302edf67105d85ea598ff10","71016d0e4e3891bda8ad5f772cf69cdef753fcf036a5ab3fab33e305afa6f6a6","88b67ce17f108a425ed8bb3c6e485769bed779f15d17aede16c69bb5a4b072bb","94782475c1cfdfa7dc974aac34cab5b47a82f3e48e6ad53952eea9ed5eefdbeb","abada489f278925fca7d72bbf9b4ad5674fb3ca0efdfdc1d0588a9b17df1e60b","bdcf7eaa6c2ed83f9aae5b2a7a8c515d0128c7024f3366b637bb4b0298ee1279","c0412578f0c4fc85f34268352b4677b258afe1f4631371a0717b9a82769f9a78","c8565fd723c649099c4ef8bee4fcd676b793f9ad00394de267ffce3f5a0a1087","ccf61c498cc1611839afe5a65d63f772d88f8d1850a3156547cc35c6e9ded5ca","e17ce9a0b1d2738f5c8a06bf46e2b06a288d673809f602d07aa2e3858b23601f","e6347cfd415c61eeaefa6ac99d0d116bdfe39eb23acdffc2e202c7b9cb5a5ad4","e64fc75b7b62c30b69703b1943409a6ee2b692026b03f2bb73a3464aa7570719","edc6c269c9168a26211f84fccb8aaf2746ba0502bfb6fbd5c7eba079020b332d","efd6d2032acfd2b957ababca92c4822622f6c202cb0dca5116e62f7a0181937a","f1954ee41df9a56211a1b5f5cc10298153988812edf840e524e984c1ec4e3d7b","f9e88451136de1930ad35f68c762b7951105ded2b8a33bd488fffbed43586b79"],"recordQualifiers":{},"scopeLabel":"ORPHA:49566","sourceIds":["ORPHA:49566"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d142fa7fc96eaa58649c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0008066","HP:0001977","HP:0001063","HP:0025022","HP:0005521","HP:0011227","HP:0025475"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":25,"sourceGroups":{"orphanet":25}},"features":[{"hpoId":"HP:0008066","label":"Abnormal blistering of the skin","primary":true},{"hpoId":"HP:0001977","label":"Abnormal thrombosis","primary":true},{"hpoId":"HP:0001063","label":"Acrocyanosis","primary":true},{"hpoId":"HP:0025022","label":"Decreased erythrocyte sedimentation rate","primary":true},{"hpoId":"HP:0005521","label":"Disseminated intravascular coagulation","primary":true},{"hpoId":"HP:0011227","label":"Elevated circulating C-reactive protein concentration","primary":true},{"hpoId":"HP:0025475","label":"Erythematous macule","primary":true},{"hpoId":"HP:0100758","label":"Gangrene","primary":false},{"hpoId":"HP:0001399","label":"Hepatic failure","primary":false},{"hpoId":"HP:0011900","label":"Hypofibrinogenemia","primary":false},{"hpoId":"HP:0002958","label":"Immune dysregulation","primary":false},{"hpoId":"HP:0011029","label":"Internal hemorrhage","primary":false},{"hpoId":"HP:0002170","label":"Intracranial hemorrhage","primary":false},{"hpoId":"HP:0031365","label":"Macular purpura","primary":false},{"hpoId":"HP:0012733","label":"Macule","primary":false},{"hpoId":"HP:0002664","label":"Neoplasm","primary":false},{"hpoId":"HP:0003645","label":"Prolonged partial thromboplastin time","primary":false},{"hpoId":"HP:0008151","label":"Prolonged prothrombin time","primary":false},{"hpoId":"HP:0025452","label":"Pyoderma gangrenosum","primary":false},{"hpoId":"HP:0005543","label":"Reduced protein C activity","primary":false},{"hpoId":"HP:0004855","label":"Reduced protein S activity","primary":false},{"hpoId":"HP:0100806","label":"Sepsis","primary":false},{"hpoId":"HP:0031273","label":"Shock","primary":false},{"hpoId":"HP:0000988","label":"Skin rash","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"A life-threatening, rapidly progressive thrombotic disorder affecting mainly neonates and children that is characterized by purpuric skin lesions and disseminated intravascular coagulation. PF may progress rapidly to multi-organ failure caused by thrombotic occlusion of small and medium-sized blood vessels. There are two forms of PF that are classified according to triggering mechanisms: acute infectious (the most common form), and idiopathic PF.","mondoId":"MONDO:0018854","node":{"canonicalSlug":"acquired-purpura-fulminans","comparisons":[{"documentSha256":"c9ebd0b2598ce0353a4a5a401eb96c7afd8b92483dec7919af328ea1dd15d11b","key":"legacy-acquired-purpura-fulminans","kind":"legacy","label":"acquired purpura fulminans","memberIds":["MONDO:0018854"],"mondoId":"MONDO:0018854","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/acquired-purpura-fulminans.c9ebd0b2598ce0353a4a5a401eb96c7afd8b92483dec7919af328ea1dd15d11b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"acquired purpura fulminans","paragraphs":["A life-threatening, rapidly progressive thrombotic disorder affecting mainly neonates and children that is characterized by purpuric skin lesions and disseminated intravascular coagulation. PF may progress rapidly to multi-organ failure caused by thrombotic occlusion of small and medium-sized blood vessels. There are two forms of PF that are classified according to triggering mechanisms: acute infectious (the most common form), and idiopathic PF."],"scope":"exact","source":"MONDO","upstream":"Orphanet:49566","url":"https://monarchinitiative.org/MONDO:0018854"},"ownColumnKeys":["population-d142fa7fc96eaa58649c"],"publication":"published","relationships":[{"kind":"parent","label":"purpura fulminans","mondoId":"MONDO:0000809","slug":"purpura-fulminans"},{"kind":"parent","label":"thrombotic disease","mondoId":"MONDO:0000831","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/18838"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"044178408e27cdb8838e3e7beaf97494376775c49f2d0bf770737ff4c1938d62","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002664","is_excluded":false,"label":"Neoplasm","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2662fc3643bca780eb325211df2c9a2bdf56141e3aabdd98ef0b2618ac181963","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001063","is_excluded":false,"label":"Acrocyanosis","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"39310c9bfc957fc8973a8d1fa401fde3067a16a09d69bdec9c81071f96b60d27","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fa84b50e11babb5cc5797ddc64e19e3fc99703c0bc6a5144cde0862bd618212","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0025452","is_excluded":false,"label":"Pyoderma gangrenosum","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"430984b3788bf292257e1f452af5a316862f348073b78810ea8d1f7d2e18c471","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025475","is_excluded":false,"label":"Erythematous macule","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4ace8e7ed5e01dd1ad04ff79cc40446c1738d0337573693ed1464aedc3b0bea1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011227","is_excluded":false,"label":"Elevated circulating C-reactive protein concentration","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4b9a772f5085301d10831edc97003a3749313fa02d8e4a195be432a4111a7377","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000988","is_excluded":false,"label":"Skin rash","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4dace2f4c746469366a9634a2c9169b3a2074a0088737ca5a4a22e4d5748d725","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031365","is_excluded":false,"label":"Macular purpura","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"56a00600c8b3141cd9a7465479362c239601f1352a75fcb1ee7fb389bf4b7b12","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005543","is_excluded":false,"label":"Reduced protein C activity","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"668e4a5ce6605fe5e7dbae54d8cf0b0de83c0ad2c302edf67105d85ea598ff10","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"71016d0e4e3891bda8ad5f772cf69cdef753fcf036a5ab3fab33e305afa6f6a6","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100806","is_excluded":false,"label":"Sepsis","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88b67ce17f108a425ed8bb3c6e485769bed779f15d17aede16c69bb5a4b072bb","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008066","is_excluded":false,"label":"Abnormal blistering of the skin","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94782475c1cfdfa7dc974aac34cab5b47a82f3e48e6ad53952eea9ed5eefdbeb","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004855","is_excluded":false,"label":"Reduced protein S activity","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"abada489f278925fca7d72bbf9b4ad5674fb3ca0efdfdc1d0588a9b17df1e60b","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002170","is_excluded":false,"label":"Intracranial hemorrhage","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bdcf7eaa6c2ed83f9aae5b2a7a8c515d0128c7024f3366b637bb4b0298ee1279","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003645","is_excluded":false,"label":"Prolonged partial thromboplastin time","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0412578f0c4fc85f34268352b4677b258afe1f4631371a0717b9a82769f9a78","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012733","is_excluded":false,"label":"Macule","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8565fd723c649099c4ef8bee4fcd676b793f9ad00394de267ffce3f5a0a1087","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011029","is_excluded":false,"label":"Internal hemorrhage","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ccf61c498cc1611839afe5a65d63f772d88f8d1850a3156547cc35c6e9ded5ca","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001977","is_excluded":false,"label":"Abnormal thrombosis","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e17ce9a0b1d2738f5c8a06bf46e2b06a288d673809f602d07aa2e3858b23601f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031273","is_excluded":false,"label":"Shock","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6347cfd415c61eeaefa6ac99d0d116bdfe39eb23acdffc2e202c7b9cb5a5ad4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025022","is_excluded":false,"label":"Decreased erythrocyte sedimentation rate","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e64fc75b7b62c30b69703b1943409a6ee2b692026b03f2bb73a3464aa7570719","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008151","is_excluded":false,"label":"Prolonged prothrombin time","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edc6c269c9168a26211f84fccb8aaf2746ba0502bfb6fbd5c7eba079020b332d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005521","is_excluded":false,"label":"Disseminated intravascular coagulation","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"efd6d2032acfd2b957ababca92c4822622f6c202cb0dca5116e62f7a0181937a","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002958","is_excluded":false,"label":"Immune dysregulation","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f1954ee41df9a56211a1b5f5cc10298153988812edf840e524e984c1ec4e3d7b","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001399","is_excluded":false,"label":"Hepatic failure","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f9e88451136de1930ad35f68c762b7951105ded2b8a33bd488fffbed43586b79","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49566","disease_name":"Acquired purpura fulminans","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011900","is_excluded":false,"label":"Hypofibrinogenemia","onset_id":null,"reference":"ORPHA:49566","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018854\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:49566</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A life-threatening, rapidly progressive thrombotic disorder affecting mainly neonates and children that is characterized by purpuric skin lesions and disseminated intravascular coagulation. PF may progress rapidly to multi-organ failure caused by thrombotic occlusion of small and medium-sized blood vessels. There are two forms of PF that are classified according to triggering mechanisms: acute infectious (the most common form), and idiopathic PF.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018854\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"acquired-purpura-fulminans","sourceDocuments":[{"name":"MONDO: acquired purpura fulminans","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018854"}],"sourceNote":"","synonyms":["acquired PF","acquired purpura fulminans"],"takeawayHtml":"","title":"acquired purpura fulminans"},"schemaVersion":1}
